Tag: Starpharma
Starpharma: Advances progress for COVID-19 nasal spray
During the September quarter, Starpharma (SPL) achieved several milestones with its SPL7013 COVID-19 nasal spray
Additionally, the pharmaceutical company made progress with its...
Starpharma: Raises $45M for next phase of growth
Pharmaceutical company Starpharma (SPL) has raised $45 million via an oversubscribed share placement
All up, 30 million new shares will issued to institutional,...
Starpharma: Receives $1M MRFF funding for COVID-19 nasal spray
Starpharma (SPL) has been awarded $1M in matched funding by the Australian Government's Medical Research Future Fund (MRFF)
This funding will also enable...
Starpharma: Updates market on nasal spray
Starpharma has provided updates on its COVID-19 nasal protection spray, which uses antiviral dendrimer SPL7013
Already the company has identified a manufacturer and...